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Abstract
Background: Open heart surgery is associated with high occurrence of atrial fibrillation (AF), subsequently increasing the
risk of post-operative ischemic stroke. Concomitant with open heart surgery, a cardiac ablation procedure is commonly
performed in patients with known AF, often followed by left atrial appendage closure with surgery (LAACS). However, the
protective effect of LAACS on the risk of cerebral ischemia following cardiac surgery remains controversial. We have
studied whether LAACS in addition to open heart surgery protects against post-operative ischemic brain injury regardless
of a previous AF diagnosis.
Methods: One hundred eighty-seven patients scheduled for open heart surgery were enrolled in a prospective, open-
label clinical trial and randomized to concomitant LAACS vs. standard care. Randomization was stratified by usage of oral
anticoagulation (OAC) planned to last at least 3 months after surgery. The primary endpoint was a composite of post-
operative symptomatic ischemic stroke, transient ischemic attack or imaging findings of silent cerebral ischemic (SCI)
lesions.
Results: During a mean follow-up of 3.7 years, 14 (16%) primary events occurred among patients receiving standard
surgery vs. 5 (5%) in the group randomized to additional LAACS (hazard ratio 0.3; 95% CI: 0.1–0.8, p = 0.02). In per protocol
analysis (n= 141), 14 (18%) primary events occurred in the control group vs. 4 (6%) in the LAACS group (hazard ratio 0.3;
95% CI: 0.1–1.0, p = 0.05).
Conclusions: In a real-world setting, LAACS in addition to elective open-heart surgery was associated with lower risk of
post-operative ischemic brain injury. The protective effect was not conditional on AF/OAC status at baseline.
Trial registration: LAACS study, clinicaltrials.gov NCT02378116, March 4th 2015, retrospectively registered.
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Background
Atrial fibrillation (AF) is a common complication after
open heart surgery and is associated with both early
perioperative and late post-operative stroke [1–5]. Previ-
ous studies report incident AF in 10 to 65% of patients
after open heart surgery [1, 6], with highest incidences
after a combination of coronary artery bypass grafting
(CABG) and valve surgery [7]. In patients with non-
operative AF, the risk of ischemic stroke is markedly re-
duced by adequate OAC [8]. However, the management
of post-operative AF is still a challenge and is by some
regarded as a transient phenomenon not requiring inter-
vention [9, 10]. The risk of bleeding poses a significant
limitation to the use of OAC, which consequently in-
creases focus on left atrial appendage (LAA) closure [11,
12], as the LAA is a predilection site for thrombus for-
mation during AF [13, 14]. Importantly, the patient
population undergoing open heart surgery is often frail
and carry comorbidities such as hypertension and
chronic obstructive pulmonary disease, which add risk
of future AF and stroke complications [15]. Moreover, a
large fraction of these elderly individuals also have sub-
clinical AF that portends an adverse prognosis compar-
able to recognized AF [16]. It is therefore conceivable
that LAACS in conjunction with open heart surgery
could mitigate the risk of stroke both in patients with
and without overt AF at time of surgery. Notwith-
standing, the evidence for routine use of LAACS
during elective open-heart surgery is controversial.
Accordingly, the primary aim of this study was to in-
vestigate the long-term effect of LAACS on cerebral
ischemia following scheduled open-heart surgery. We
hypothesized that surgical LAACS protects against
cerebral ischemia in the following years regardless of
AF status at time of surgery.
Methods
Study design
From August 2010 to September 2015, we conducted a
prospective, randomized, open label study on patients
scheduled for open heart surgery to receive either con-
comitant LAACS or standard care. The LAACS study is
registered at clinicaltrials.gov (NCT02378116). The
study was initiated at the Department of Thoracic Sur-
gery, University Hospital of Gentofte, Denmark. During
2010, the Department of Thoracic Surgery was trans-
ferred and merged with the equivalent department at
Rigshospitalet, Copenhagen, where the study continued.
Patients were randomized the day before surgery after
signing informed consent. To ensure a balanced distri-
bution of patients receiving OAC between the two
study-arms, randomization was stratified according to
ongoing use of anti-coagulation. This included patients
undergoing surgical biological valve replacement until
January 2012, as post-operative anti-coagulation was no
longer recommended [17].
Patients were randomized 1:1 by a computer-generated
randomization in blocks of 16 patients. Since we expected
substantial cross-over, procedures were monitored at the
end of each operation for cross-over. If one of the study
groups reached a discrepancy of 4 between randomization
allocation and the actual operation, the randomization
block was suspended and substituted by a 3:1 randomization
in the next block (n 16) to compensate for the difference.
The study protocol recommended double closure with
both purse string and running suture, although this
closure method was not mandatory. Patients were in-
vited to pre-surgery magnetic resonance imaging (MRI)
scan (MRI-0) whenever possible. Immediately after dis-
charge, all patients were invited for a post-operative
baseline brain MRI scan (MRI-1) scheduled between 2
and 4 weeks after discharge and a follow-up MRI (MRI-
2) performed at least 6 months after surgery.
Study population
Consecutive patients undergoing planned first-time open-
heart surgery (CABG, valve surgery or a combination of
both) during the study period were asked to participate in
the trial, provided that their residence was within 40 km
radius from the hospital. Major exclusion criteria included
endocarditis and implanted pacemaker (see Additional file 1:
Table S1 for full inclusion and exclusion criteria). All
patients in the LAACS arm were invited to undergo post-
operative transesophageal echocardiography (TEE) by a
senior cardiologist to visualize the LAA and the quality of
the closure. Patients could decline TEE and remain in the
study for follow-up.
MRI analyses
The brain MRI included imaging of cerebrum, cerebel-
lum and brainstem. All MRIs were reviewed by a fellow
in radiology with years of experience, and the possibil-
ity of consulting unclear cases with a neuro radiologist.
Radiologists were blinded to randomization. MRI-
criteria for silent cerebral infarcts (SCI) were equivalent
to those in the Framingham offspring study, i.e., cavi-
tating lesions ≥3 mm with CSF-like signal intensities
on T1, T2 and FLAIR [17]. Both acute and old SCIs
were included. Differentiation from dilated Virchow-
Robins spaces (dVRS) was attempted using the location
criterion (i.e., excluding lesions along perforating or medul-
lary arteries or in the lower third of the basal ganglia) and
shape criterion (i.e. oval lesions criteria along the penetrat-
ing arteries with intensity close to CSF were considered
dVRS) [18].
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Endpoint definitions
The pre-specified endpoint protocol was post-operative
cerebral ischemic events defined as a composite of first
ischemic stroke or transient ischemic attack (ICD-10:
DG450–9), increased amount of SCI between MRI-1 and
MRI-2 and post-operative findings of SCI by brain
imaging (computed tomography [CT] or MRI) performed
in clinical settings unrelated to study enrollment.
Secondary outcomes were strict symptomatic ischemic
strokes. That is, ischemic stroke or transient ischemic
attack, excluding cerebral ischemic events classified
solely on imaging findings and all-cause mortality. We
followed all patients for at least 1 year after surgery. The
clinical outcomes Ischemic stroke and transient ischemic
attack were ascertained by following the patient’s elec-
tronic records yearly. Patients vital status were obtained
using data from the Central Office of Civil Registration,
which comprises all citizens in Denmark. Additionally,
telephone interviews were performed after minimum 1
year to ascertain whether the patients had experienced
signs of clinically unrecognized cerebral ischemia. If so,
it would be registered as a transient ischemic attack.
Power calculation
We based our power calculations on the incidence of AF
among patients undergoing open heart surgery and the
expected variation in a combined end-point of clinical
stroke, transitory ischemic attack (TIA), and occurrence
of silence infarctions, which included findings of newly
silent lacunar infarctions with imaging in clinical settings
and changes on number of lacunar infarctions from
baseline MRI (at discharge) to MR2. Incident stroke oc-
curs in 1–5% of heart surgery patients [19–21], often
within the first months following surgery [22]. At the
initiation of the study, there were almost no studies with
long-term MRI follow-up after open heart surgery [23].
Around 50% of patients undergoing surgery of carotid
arteries have lacunar infarctions on MRI [24], and the
presence of AF roughly doubles the risk of strokes [25].
We assumed an equivalent prevalence of 50–70% of in-
farctions counting both subclinical and clinical peri-
operative strokes/TIA. This is equivalent to findings on
CABG surgery [26] and valve surgery [23], respectively,
where MRI changes occur in 40–70% of patients. There-
fore, we assumed that closure of the LAA would reduce
findings on MRI scans and clinical strokes/TIA from a
total of 60 to 35% with a 5% margin. With a significance
level of 5%, we calculated that we could demonstrate
this benefit with a 5% margin and 90% power by includ-
ing 90 patients. After the initiation of the study, it
became apparent that MRI scans were not feasible for
many patients. Hence, we recalculated the number of
patients needed based on newer data on occurrence of
stroke after heart surgery [27–30], considering a three-
to five-fold increased risk of stroke in patients with non-
contracting, patent LAA who had undergone MAZE-
procedure during surgery [31] combined with an occur-
rence of images of infarction after CABG over 20% [32],
the latter including MRI changes [23, 26]. Without other
available evidence on truly long-term follow-up studies
after heart surgery associated to AF, we calculated that
we could investigate the protective effect of LAACS
based on any signs of cerebral infarction (stroke, TIA or
imaging evidence of silent cerebral ischemia) through
randomization of 400 patients, if LAACS could
reduce events from 65 to 45% with a significance
level of 5 and 91% power. With 88% power, a second
calculation showed a necessity of including 100 pa-
tients in each group. Therefore, we maintained our
plan to randomize 200 patients.
Statistical analysis
All analyses were performed using SAS statistical soft-
ware package version 9.4 (SAS Institute Inc., Cary, NC).
Continuous variables are presented as mean±standard
deviation and categorical variables as number and per-
centages. After inspection for normality, differences be-
tween the LAACS and control group were evaluated by
Student’s t-test (continuous variables) and by Chi-square
and Fisher’s exact test (categorical variables) where ap-
propriate. Cause specific Cox time to event analysis was
used to estimate the rate ratios for incident stroke and
all-cause mortality according to randomization. A cumu-
lative probability plot of incident stroke according to
randomization was generated by Fine and Gray compet-
ing risk regression using death as a competing event
[33]. All outcome analyses were performed as intention
to treat and per protocol. Patients were considered to
have complied with the treatment protocol when LAAC
was performed according to randomization. A sensitivity
analysis was performed to evaluate model dependence
on imaging findings by comparing overall results with a
model that only included events due to symptomatic is-
chemic stroke or transient ischemic attack. A two-tailed
p-value < 0.05 was regarded as statistically significant.
Ethics
The project was approved by Regional Ethics Committee
of Capital Region Denmark (protocol number H-3-2010-
017) and follows the Helsinki declaration.
Results
Of 914 patients invited to participate, 205 (22.4%) were
enrolled. Of those, 187 (91.2%) were randomized and 141
(75.4%) ultimately followed the treatment protocol (see
Additional file 2: Figure S1). During the second year of the
study, discrepancy between randomization and performed
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procedure reached a difference of four (due to overweight
of patients randomized to LAACS who did not undergo
closure), and the following randomization blocks of 16 pa-
tients were switched to 3:1 randomization. The rest of the
study randomization continued 1:1.
Two patients randomized to additional LAACS
crossed over due to technical difficulties during the
operation, and the LAACS procedure was avoided. In
five patients with known paroxysms of AF, the surgeons
changed the planned operation adding intra-operative
ablation and closing the left appendage, despite
randomization to the control group. Baseline character-
istics of randomized participants are showed in Table 1.
No adverse events such as bleeding due to LAACS pro-
cedure were recorded. 75 (40%) patients underwent both
of the planned brain MRIs. Thirty patients had brain in-
farctions in pre-surgery MRI. Of 74 patients who under-
went subsequent MRI shortly after discharge, 11 had
SCI at post-discharge MRI. Among 75 available sets of
post-discharge and long-term MRI, only two had new
SCI, one in each group.
There were no detectable differences in randomization
to LAACS, age or gender between patients that had the
planned brain MRI scans vs. those that did not (all p > 0.35,
Additional file 3: Table S2). 10 patients from the LAACS
group accepted the invitation to undergo TEE (mean
524 days after surgery date). In none of the cases could the
lumen of the LAA or any flow from the appendage orifice
be identified.
Clinical outcomes
Follow up was up to 6 years, mean 3.7 ± 1.6 years
(totaling 684 patient years of follow-up). End of study
was 1 year after reaching our pre-specified sample size
of 200 patients. Five patients were lost to follow-up for
the primary endpoint and 24 (13%) died. At end of study
telephone-interviews, no patient was suspected to have
suffered a clinically unrecognized ischemic cerebral
event. In the intention-to-treat analysis, there were 5
(5%) primary events in the LAACS-group and 14 (16%)
in the control group (hazard ratio 0.3; 95% CI: 0.1–0.8,
p = 0.02, Table 2, Fig. 1 and Additional file 4: Table S3
Contingency table of individual events). Tests of inter-
action revealed no dependency of the preventative effect
of LAACS on baseline AF status, CHA2DS2-VASc score
or use of OAC (p = 0.55, p = 0.56 and p = 0.49 for
interaction, respectively). Secondary outcome analysis
revealed no detectable difference in all-cause mortality
(p = 0.79) between the LAACS group (n = 12, 12%) vs.
the controls (n = 12, 14%, Table 2). Similarly, in a sensi-
tivity analysis that excluded the eight patients that
underwent primary events only based on radiological
findings, there was a trend but no longer a significant
reduction in ischemic strokes among patients random-
ized to LAACS (p = 0.08, Table 2 and Fig. 2).
In the per protocol sensitivity analysis (Table 3), there
were 4 (6%) primary events in the LAACS group vs.
14 (18%) in the control arm (hazard ratio 0.3; 95%
Table 1 Baseline characteristics according to randomized left
atrial appendage closure
Variable Not closed
(n = 86)
Closed
(n = 101)
Age – years 69.3 ± 8.8 67.6 ± 9.6
Men - n (%) 75 (87.2) 84 (83.2)
Clinical characteristics
Congestive heart failure - n (%) 15 (17.9) 16 (15.8)
Atrial fibrillation - n (%) 12 (12.8) 18 (16.8)
Diabetes - n (%) 19 (22.1) 31 (30.7)
Hypertension - n (%) 60 (69.8) 75 (74.3)
CHADS-VASc – unit 2.9 ± 1.4 2.9 ± 1.5
Prior stroke - n (%) 15 (17.4) 11 (10.9)
Chronic kidney diseasea - n (%) 14 (16.3) 15 (14.9)
Medicine
ASA - n (%) 69 (80.2) 75 (74.3)
Clopidogrel - n (%) 14 (16.3) 19 (18.8)
OAC
VKA - n (%) 26 (30.2) 36 (35.6)
NOAC - n (%) 2 (2.2) 2 (2.0)
Beta-blocker - n (%) 47 (54.7) 61 (60.4)
Verapamil - n (%) 4 (4.5) 2 (2.0)
Calcium-blocker - n (%) 19 (21.3) 34 (33.7)
Digoxin - n (%) 5 (5.6) 3 (3.0)
Renin-angiotensin system blocker - n (%) 40 (46.5) 54 (53.5)
Amiodarone - n (%) 23 (26.7) 18 (17.8)
Statin - n (%) 74 (86.0) 81 (80.2)
Procedural characteristics
Surgery type
AVR only - n (%) 17 (19.1) 17 (16.8)
AVR with CABG - n (%) 20 (22.5) 22 (21.8)
AVR with aortic surgery - n (%) 1 (1.1) 1 (1.0)
AVR with MVR - n (%) 0 (0) 2 (2.0)
Aortic surgery only - n (%) 1 (1.1) 0 (0)
CABG only - n (%) 40 (46.5) 50 (49.5)
CABG with MVR - n (%) 2 (2.3) 2 (2.0)
MVR only - n (%) 4 (4.5) 7 (6.9)
Tricuspid surgery only - n (%) 1 (1.2) 0 (0)
Perioperative atrial fibrillation - n (%) 52 (60.5) 50 (50.0)
Abbreviations CHADS-VASc Congestive heart failure, hypertension, age
[≥75 years], diabetes, stroke – peripheral vascular disease, age [≥65 years], sex-
category, OAC Oral anticoagulation, VKA Vitamin K-antagonist, NOAC Novel oral
anticoagulation, IQR: interquartile range
aeGFR< 30 ml/min
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CI: 0.1–1.0, p = 0.05). Of note, in the control group, 9
(64%) of the 14 primary events occurred beyond the
first year of follow-up (Fig. 1). Secondary outcome
analyses again revealed no detectable difference in
overall survival or strict symptomatic ischemic strokes
between the two study-arms (Table 3).
The datasets used during the current study are available
from the corresponding author on reasonable request.
Discussion
This is the first randomized study where LAACS in
addition to first-time open-heart surgery (CABG, valve
or combination of both) seems to protect against post-
operative cerebral ischemic events several years after
surgery. Despite a substantial number of cross-overs,
results were consistent in the intention-to-treat and per-
protocol analyses. Furthermore, the impact during long-
term follow-up should become visible in patients with
AF, which may be offset with effective anticoagulation.
Thus, LAACS seems as a safe, low cost and easily
feasible procedure that may mitigate risk of post-
operative cerebral ischemia among patients undergo-
ing planned heart surgery.
Although encouraging, these results must be inter-
preted cautiously. The study is not powered to demon-
strate a protection against stroke. Furthermore, the
rationale for including SCI in the composite primary
endpoint is rather indirect [34, 35]. Yet, we found a
trend towards higher stroke and TIA events in the con-
trol group (p = 0.07), which seems to support the rele-
vance of SCI as true brain damage.
Comparing our findings to available literature, it is
generally accepted that there is very little evidence on
the effects of surgical closure of the LAA [36]. A previous
study from 2000 by Johnson et al. showed no safety
issues regarding LAACS among the 437 patients
included, where of which 43 appendages were stapled
and 391 were sutured. [37] In a recent systematic re-
view of LAA closure, the authors concluded that
there are no randomized clinical trials and that pub-
lished evidence is insufficient to assess the benefits of
LAACS but there is seemingly no adverse risk associ-
ated with the procedure [36].
Of note, most of the primary events in the present
control group were late ischemic strokes well clear of
the time of surgery and the complex array of risk
Table 2 Proportion of patients meeting endpoints according to
randomized left atrial appendage closure, stratified by use of
anti-coagulants
Endpoint Not closed
(n = 86)
Closed
(n = 101)
Hazard ratio P-value
Primary eventsa 14 (16.3%) 5 (5.0%) 0.3 [95% CI: 0.1–0.8] 0.0168
Clinical strokeb 8 (10.0%) 3 (3.0) 0.3 [95% CI: 0.1–1.1] 0.0763
Death 12 (14.0%) 12 (11.9%) 0.8 [95% CI: 0.43–1.9] 0.6562
aDefined as first of postoperative symptomatic ischemic stroke, transient
ischemic attack or imaging evidence of new silent infarct
bExcluding 8 patients that were classified as primary events due to
imaging findings
Fig. 1 Cumulative probability of primary events (combined ischemic stroke, transitory ischemic stroke or silent ischemic images) according to
randomized LAACS (left atrial appendage closure with surgery)
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factors related to perioperative stroke. This is in sup-
port of the theory that post-operative ischemic events
by large are unrelated to the surgical procedure per
se, but instead originate from LAA thrombus forma-
tion induced by AF. The facts that LAA is a prevalent
site of thrombus formation during AF and that the
incidence of AF after open heart surgery is as high as
50–60% further supports this hypothesis [38]. In turn,
this may also explain why the effect of LAACS was
not altered by baseline AF status, as there is a general
consensus that post-operative AF is associated with
late post-operative stroke [1, 22, 39]. Thus, LAACS
may act by blocking a causal mechanism for late
ischemic strokes induced by either pre- or post-
operative AF.
A major concern of surgical versus percutaneous
LAA closure is the risk of incomplete closure [40],
although there is very little evidence that supports
this notion [11]. In our study, we found no signs of
incomplete LAACS among the 10 participants that
underwent TEE. With any of the surgical techniques,
there is a risk of incomplete LAACS, though it varies
greatly depending upon the surgical technique utilized
and the definition of surgical failure [41]. Neverthe-
less, a recent experimental study in vitro comparing
epicardial closure supports double closure with both
purse string and running suture as recommended in
our protocol [42].
Study limitations
The study was halted before reaching the planned
randomization of 200 patients due to competing studies
recruiting patients for heart surgery. Nevertheless,
according to our findings, it would be sufficient to
include 35 patients in each group with 90% power to
find a difference on the combination of stroke, TIA and
SCI 2 years after surgery with a significance level of 5%.
Furthermore, due to the frailty of the patients included,
the discomfort of cerebral MRI and the physically- and
mentally challenging period postoperatively, it was only
possible to perform full sets of MRI scans in 75 patients.
However, the patients who were not able to participate in
all MRI scans agreed to stay active in the study for future
clinical follow up. The fact that all patients did not
undergo the planned MRI scans may have introduced a
selection-bias, as frail patients may be more prone to
decline the brain MRI scans. However, results from sensi-
tivity analyses restricted to symptomatic ischemic strokes
Fig. 2 Cumulative probability of symptomatic ischemic stroke or transient ischemic attack (image findings excluded) according to randomized
LAACS (left atrial appendage closure with surgery)
Table 3 Proportion of patients meeting endpoints according to
per-protocol left atrial appendage closure stratified by use of
anti-coagulants
Endpoint Not closed
(n = 77)
Closed
(n = 64)
Hazard ratio P-value
Primary eventsa 14 (18.2%) 4 (6.3%) 0.3 [95% CI: 0.1–0.9] 0.0237
Clinical strokeb 8 (11.3%) 2 (3.2%) 0.3 [95% CI: 0.1–1.3] 0.0907
Death 10 (13.0%) 6 (9.4%) 0.7 [95% CI: 0.3–2.3] 0.7067
aDefined as first of postoperative symptomatic ischemic stroke, transient
ischemic attack or imaging evidence of new silent infarct
bExcluding 8 patients that were classified as primary events due to
imaging findings
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support the results that included imaging findings. An-
other limitation is the fact that only 10 patients accepted
postoperative TEE. An unnoticed incomplete LAA clos-
ure, may thus have provoked events.
Conclusion
In a real-world setting, LAACS during elective open-
heart surgery was associated with a lower risk of ische-
mic cerebral events following open heart surgery.
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